Covid-19 offers an opportunity for rethinking the topic of China and global health governance. This paper first draws attention to the notion of “global health” by offering a brief contour of China’s contributions to solve the world’s health burden throughout modern history. The author argues that it may be wise for both developed and developing countries to view global health less as an extension of development aid and more as a public good. Assurance of health as a public good necessitates equity-based contributions by all. The paper then touches upon the renewed interest in linking health provision and national security, which pitches China as a competitor against established health industry leaders like the United States. International harmonization of the rules of trade in health products for emergency responses and the negative spillover effects produced on health provision by economic sanctions deserve continuous research attention.
[IT] Scrivere sul noto tema della Cina del secondo dopoguerra in relazione al regionalismo in Asia orientale è un compito straordinariamente complesso. Le difficoltà iniziano dal dover esordire (così come si sentirebbero costretti a fare gli autori di quasi tutti i saggi dedicati alle dinamiche politico-economiche di questa parte del mondo) con una lista di Stati-nazione appartenenti all’Asia orientale. I criteri adottati per la stesura di una lista di tal genere spazierebbero dall’ideologico, all’economico, al culturale.
Le valutazioni mainstream sull’evoluzione dei rapporti tra la Cina e i dieci Paesi membri dell’Associazione delle Nazioni del Sud-est asiatico (ASEAN), specialmente nell’ultimo decennio,... Read More
It would be erroneous to see Southeast Asia as little more than an object for strategic competition between Beijing, on one hand, and Washington and its allies, on the other.
